Previous
Previous

Plasma Biomarkers Ascertained with Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review

Next
Next

The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease